sensitivity 3 acute insulin response to glucose). Participants received standardized meals during the 24 h prior to each ivGTT. We previously reported the effects of sleep restriction versus normal sleep on sleep stages, insulin sensitivity, and insulin response from this cohort (1,2,4). The effects of sleep condition on glucose homeostasis were assessed using a mixed-effects regression model.
On average, participants slept 7.8 6 0.1 h during normal sleep, 4.3 6 0.02 h during sleep restriction, and 9.7 6 0.2 h during sleep recovery (P , 0.001; all data are mean 6 SEM). Weight measured prior to each ivGTT was similar between sleep conditions (P 5 0.21). Insulin sensitivity was reduced by 23% after sleep restriction relative to normal sleep, which improved after recovery sleep (Fig. 1A) . Acute insulin response to glucose did not differ between conditions (Fig. 1B) . Disposition index was reduced by 16% following sleep restriction relative to normal sleep, consistent with increased diabetes risk, which reverted back to normal sleep levels after recovery sleep (Fig. 1C) .
A common question is whether, and how quickly, an individual can recover from the adverse effects of sleep loss on glucose homeostasis. We have demonstrated that 2 nights of recovery sleep averaging nearly 10 h per night following 4 nights of sleep restriction in healthy young lean men is sufficient to improve insulin sensitivity and restore disposition index (a marker of diabetes risk) to the levels observed after normal sleep. Our findings suggest that catching up on sleep can reverse the negative metabolic effects of short-term sleep restriction. These data are clinically relevant because such sleep patterns (i.e., short-term sleep restriction on workdays and recovery sleep on weekends) are quite common in modern society (5). Future studies in real-world settings are needed to investigate whether catching up on sleep could be an effective behavioral intervention in the prevention and management of type 2 diabetes.
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